The usefulness of non-human primates in central nervous system safety pharmacology

被引:11
|
作者
Porsolt, Roger D. [1 ]
机构
[1] Porsolt SAS, ZA Glatigne, F-53940 Le Genest St Isle, France
关键词
Biting; Cognition; Delayed matching/non-matching-to-sample; Dystonia Executive function; Extrapyramidal symptoms (EPS); Frustration-aggression; Methods Non-human primates (NHP); Object retrieval; INTRAVENOUS PHARMACOKINETIC PARAMETERS; QUALITATIVE EVALUATION; ALZHEIMERS-DISEASE; OBJECT RETRIEVAL; RHESUS-MONKEYS; ANIMAL-MODELS; DRUGS; RAT; EXTRAPOLATION; PERFORMANCE;
D O I
10.1016/j.vascn.2013.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The present paper will suggest, on the basis of experimental evidence, that several non-human primate (NHP) procedures can be uniquely useful and relevant for central nervous system (CNS) safety pharmacology purposes. Methods and results: Classical antipsychotics (e.g. haloperidol) but not atypical antipsychotics (e.g. clozapine), in contrast to rodents, induce behavioral signs in NHP which are clearly homologous to those observed in humans and thus have high translational value. Operant techniques (delayed matching/non-matching-to-sample) and non-operant techniques (object retrieval) can be used in NHP to assess the facilitating and impairing effects of drugs on cognition. Brain structures sub-serving these functions are closer to humans in NHP than in rodents suggesting that drug data from NHP translate better to humans. Biting into a rubber tube can be induced in squirrel monkeys by exposure to non-reinforcement (frustration). This model is close to human notions of frustration/aggression, and is ethically more acceptable than methods using shock or animal fighting. It could therefore serve as a model of drug-induced irritability with potentially high translational value. Conclusion: There are cogent scientific reasons for selecting NHP in CNS and other safety pharmacology areas. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    FONTAN, M
    LILLE MEDICAL, 1966, 11 (01): : 90 - &
  • [42] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    不详
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1965, 154 (02): : 497 - &
  • [43] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    VOTAVA, Z
    ACTIVITAS NERVOSA SUPERIOR, 1965, 7 (03): : 350 - &
  • [44] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    KARZEL, K
    MEDICINA ET PHARMACOLOGIA EXPERIMENTALIS, 1965, 13 (06): : 411 - &
  • [45] Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
    Burdo, Tricia H.
    Chen, Chen
    Kaminski, Rafal
    Sariyer, Ilker K.
    Mancuso, Pietro
    Donadoni, Martina
    Smith, Mandy D.
    Sariyer, Rahsan
    Caocci, Maurizio
    Liao, Shuren
    Liu, Hong
    Huo, Wenwen
    Zhao, Huaqing
    Misamore, John
    Lewis, Mark G.
    Simonyan, Vahan
    Xu, Ethan Y.
    Cradick, Thomas J.
    Gordon, Jennifer
    Khalili, Kamel
    GENE THERAPY, 2024, 31 (5-6) : 224 - 233
  • [46] The safety assessment and the pharmacodynamics evaluation of therapeutic cytokine in non-human primates
    Li, Wei
    Xu, Yixuan
    Zhou, Xin
    Zhu, Dan
    Xiao, Meng
    Zhou, Yulin
    Yang, Zhijie
    Li, Haodong
    Pang, Bo
    Song, Xinghai
    Xiao, Yan
    Shi, Wenting
    Qian, Qian
    Gu, Qingyang
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Biodistribution and Safety Study of AAV9 in Non-Human Primates
    Lostal, William
    Roudaut, Carinne
    Deschamps, Jack-Yves
    Richard, Isabelle
    MOLECULAR THERAPY, 2018, 26 (05) : 190 - 190
  • [48] Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates
    Tricia H. Burdo
    Chen Chen
    Rafal Kaminski
    Ilker K. Sariyer
    Pietro Mancuso
    Martina Donadoni
    Mandy D. Smith
    Rahsan Sariyer
    Maurizio Caocci
    Shuren Liao
    Hong Liu
    Wenwen Huo
    Huaqing Zhao
    John Misamore
    Mark G. Lewis
    Vahan Simonyan
    Elaine E. Thompson
    Ethan Y. Xu
    Thomas J. Cradick
    Jennifer Gordon
    Kamel Khalili
    Gene Therapy, 2024, 31 : 224 - 233
  • [49] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    GADDUM, J
    BRITISH MEDICAL BULLETIN, 1965, 21 (01) : 1 - &
  • [50] PHARMACOLOGY OF CENTRAL NERVOUS SYSTEM
    LABORIT, H
    AGRESSOLOGIE, 1965, 6 (02): : R59 - +